Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-7 of 7
  • previous
  • 1
  • next
Item hits:
Issue DateTitleAuthor(s)
19-May-2015Apoptosis inhibitor TRIAP1 is a novel effector of drug resistanceAdams, C; Cazzanelli, G; Rasul, S; Hitchinson, B; Hu, Y, et al
10-Feb-2016miR-515-5p controls cancer cell migration through MARK4 regulationPardo, OE; Munro, CE; Castellano, L; Hu, Y; Mauri, F, et al
19-Dec-2017Metabolomics reveals novel blood plasma biomarkers associated to the BRCA1-mutated phenotype of human breast cancerRoig, B; Rodriguez-Balada, M; Samino, S; Lam, EW; Guaita-Esteruelas, S, et al
4-Jan-2016DNA methylation profiling to assess pathogenicity of BRCA1 unclassified variants in breast cancer.Flower, KJ; Shenker, NS; El-Bahrawy, M; Goldgar, DE; Parsons, MT, et al
19-Jul-2016Direct targeting of the Ras GTPase superfamily through structure-based designZhao, W; Jamshidiha, M; Lanyon-Hogg, T; Recchi, C; Cota, E, et al
1-Jun-2018The FOXO3-FOXM1 Axis: a key cancer drug target and a modulator of cancer drug resistanceYao, S; Fan, YN; Lam, EW; Biotechnology and Biological Sciences Research Council (BBSRC); Imperial College Trust, et al
18-Jun-2018O-GlcNAcylation mediates metastasis of cholangiocarcinoma through FOXO3 and MAN1A1Phoomak, C; Silsirivanit, A; Park, D; Sawanyawisuth, K; Vaeteewoottacharn, K, et al